Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Journal of Human Hypertension|June 20, 2025
Hypertensive urgencies and emergencies in the cardiology emergency department: epidemiology, patient profile, and managementPanagiotis Theofilis, Nikolaos Nakas, Thomais Lamprou, et al.Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatmentIppokratis Messaritakis, Michalis Nikolaou, Fillipos Koinis, et al.Biomedicines|January 23, 2024
ES-SCLC Patients with PD-L1<sup>+</sup> CTCs and High Percentages of CD8<sup>+</sup>PD-1<sup>+</sup>T Cells in Circulation Benefit from Front-Line Immunotherapy TreatmentAnastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis, et al.Oncology|January 15, 2009
Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II studyCharalambos Kouroussis, Lambros Vamvakas, Nikolaos Vardakis, et al.Journal of Geriatric Oncology|October 28, 2018
Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)Natalia Asimakopoulou, John Souglakos, Nikolaos Kentepozidis, et al.Cureus|September 5, 2022
Complications of Totally Implantable Central Venous Catheters (Ports) Inserted via the Internal Jugular Vein Under Ultrasound and Fluoroscopy Guidance in Adult Oncology Patients: A Single-Center ExperienceViktoria Kartsouni, Hippocrates Moschouris, Fragiskos Bersimis, et al.British Journal of Cancer|February 11, 2022
Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancerAlexios Matikas, Athanasios Kotsakis, Stella Apostolaki, et al.Minerva Ginecologica|February 8, 2019
Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I studyJohn Syrios, Charalambos Kouroussis, Athanasios Kotsakis, et al.Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptideAthanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, et al.BMC Cancer|November 25, 2010
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancerAthanasios G Pallis, Sophia Agelaki, Athina Agelidou, et al.Pageof 13